These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33504234)

  • 21. Pharmacy services at the PyeongChang 2018 Olympic and Paralympic Winter Games.
    Stuart M; Kwon YI; Rhie SJ
    Br J Sports Med; 2019 Sep; 53(17):1105-1110. PubMed ID: 30894336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescribing medications and nutritional supplements for athletes.
    Babwah T
    West Indian Med J; 2009 Sep; 58(4):352-6. PubMed ID: 20099776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asthma and athletes: therapy to compete.
    Weiler JM; Malloy C
    Clin Rev Allergy Immunol; 2005 Oct; 29(2):139-49. PubMed ID: 16251768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clarification of the Relationship between Awareness of Doping of Competitive Sports Coaches and Their Instructions to Prevent Doping].
    Yamaguchi T; Horio I; Goto M; Miyauchi Y; Izushi F
    Yakugaku Zasshi; 2016; 136(8):1185-93. PubMed ID: 27477736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sport, Society, and Anti-Doping Policy: An Ethical Overview.
    Bloodworth AJ; McNamee M
    Med Sport Sci; 2017; 62():177-185. PubMed ID: 28571026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reporting doping in sport: national level athletes' perceptions of their role in doping prevention.
    Whitaker L; Backhouse SH; Long J
    Scand J Med Sci Sports; 2014 Dec; 24(6):e515-521. PubMed ID: 24673128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asthma medication in Finnish olympic athletes: no signs of inhaled beta2-agonist overuse.
    Alaranta A; Alaranta H; Palmu P; Alha P; Pietilä K; Heliövaara M; Helenius I
    Med Sci Sports Exerc; 2004 Jun; 36(6):919-24. PubMed ID: 15179158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
    Kindermann W
    Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The use of anti-asthmatic medication among Danish elite athletes].
    Lund TK; Pedersen L; Backer V
    Ugeskr Laeger; 2007 Dec; 169(50):4355-9. PubMed ID: 18211794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Terbutaline: level the playing field for inhaled β
    Jacobson GA; Hostrup M
    Br J Sports Med; 2017 Sep; 51(18):1323-1324. PubMed ID: 27461883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of prescription drugs in athletes.
    Alaranta A; Alaranta H; Helenius I
    Sports Med; 2008; 38(6):449-63. PubMed ID: 18489193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examining pharmacists' anti-doping knowledge and skills in assisting athletes to avoid unintentional use of prohibited substances.
    Greenbaum DH; McLachlan AJ; Roubin RH; Moles R; Chaar BB
    Int J Pharm Pract; 2023 May; 31(3):290-297. PubMed ID: 36869840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
    Wolfarth B; Wuestenfeld JC; Kindermann W
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-level athletes' motivation for sport and susceptibility to doping: The mediating role of eating behaviours.
    Scoffier-Mériaux S; d'Arripe-Longueville F; Woodman T; Lentillon-Kaestner V; Corrion K
    Eur J Sport Sci; 2021 Mar; 21(3):412-420. PubMed ID: 32105185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Induced asthma and sport].
    Chenuel B
    Rev Prat; 2020 Nov; 70(9):997-1004. PubMed ID: 33739762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacists supporting athletes: a scoping review exploring the knowledge, role and responsibilities of pharmacists in preventing the unintentional use of prohibited substances by athletes.
    Greenbaum DH; McLachlan AJ; Roubin RH; Chaar BB
    Int J Pharm Pract; 2022 May; 30(2):108-115. PubMed ID: 35262700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An (un)desirable trade of harms? How elite athletes might react to medically supervised 'doping' and their considerations of side-effects in this situation.
    Overbye M
    Int J Drug Policy; 2018 May; 55():14-30. PubMed ID: 29477956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of therapeutic use exemptions at the Olympic Games and association with medals: an analysis of data from 2010 to 2018.
    Vernec A; Healy D
    Br J Sports Med; 2020 Aug; 54(15):920-924. PubMed ID: 32376674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Use Exemptions.
    Gerrard D; Pipe A
    Med Sport Sci; 2017; 62():55-67. PubMed ID: 28571022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. It is Time to Ban Rapid Weight Loss from Combat Sports.
    Artioli GG; Saunders B; Iglesias RT; Franchini E
    Sports Med; 2016 Nov; 46(11):1579-1584. PubMed ID: 27102173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.